Euroscreen S.A.

Euroscreen has established a team of advisors to provide guidance on specific aspects of our GPCR research, drug discovery and development, specifically: 

Terry J. Opgenorth, PhD, as Drug Discovery & Pre-Clinical Development Expert; Dr. Opgenorth has 20 years of experience with Abbott ultimately serving as Divisonal Vice President of Antiviral Research, Metabolic Disease Research, and Target-Lead Discovery and was responsible for the advancement of numerous projects into clinical development. 

Daniel F. Veber, PhD, Drug Discovery & Medicinal Chemistry Consultant.  Dan has had a four-decade long, ditinguished career in medicinal chemistry and peptide synthesis at GlaxoSmithKline (formerly SmithKline Beecham) and Merck, most recently serving as Senior Director of Medicinal Chemistry.